These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 11596838

  • 1. Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.
    Menendez R, Stanford RH, Edwards L, Kalberg C, Rickard K.
    Pharmacoeconomics; 2001; 19(8):865-74. PubMed ID: 11596838
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2002; 20(13):909-18. PubMed ID: 12381242
    [Abstract] [Full Text] [Related]

  • 3. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 4. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W, Wolfe J, Storms W, Srebro S, Edwards L, Johnson M, Bowers BW, Rogenes PR, Rickard K.
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 7. Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma.
    Pieters WR, Wilson KK, Smith HC, Tamminga JJ, Sondhi S.
    Treat Respir Med; 2005 Nov; 4(2):129-38. PubMed ID: 15813665
    [Abstract] [Full Text] [Related]

  • 8. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.
    Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, Rickard KA.
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1123-9. PubMed ID: 10856145
    [Abstract] [Full Text] [Related]

  • 9. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA, Plosker GL.
    Pharmacoeconomics; 2003 Jun; 21(13):951-89. PubMed ID: 12959627
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma.
    Brabson JH, Clifford D, Kerwin E, Raphael G, Pepsin PJ, Edwards LD, Srebro S, Rickard K.
    Am J Med; 2002 Jul; 113(1):15-21. PubMed ID: 12106618
    [Abstract] [Full Text] [Related]

  • 11. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
    Kim KT, Ginchansky EJ, Friedman BF, Srebro S, Pepsin PJ, Edwards L, Stanford RH, Rickard K.
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
    [Abstract] [Full Text] [Related]

  • 12. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
    Pathak DS, Davis EA, Stanford RH.
    Pharmacotherapy; 2002 Feb; 22(2):166-74. PubMed ID: 11837555
    [Abstract] [Full Text] [Related]

  • 13. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B, Faulds D.
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [Abstract] [Full Text] [Related]

  • 14. Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma.
    Volmer T, Kielhorn A, Weber HH, Wiessmann KJ.
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):525-31. PubMed ID: 10662477
    [Abstract] [Full Text] [Related]

  • 15. Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.
    Lamb HM, Culy CR, Faulds D.
    Pharmacoeconomics; 2000 Nov; 18(5):487-510. PubMed ID: 11151402
    [Abstract] [Full Text] [Related]

  • 16. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
    Creticos P, Knobil K, Edwards LD, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2002 Apr; 88(4):401-9. PubMed ID: 11991558
    [Abstract] [Full Text] [Related]

  • 17. Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma.
    Westbroek J, Pasma HR.
    Respir Med; 2000 Feb; 94(2):112-8. PubMed ID: 10714415
    [Abstract] [Full Text] [Related]

  • 18. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
    Adkins JC, Brogden RN.
    Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
    [Abstract] [Full Text] [Related]

  • 19. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 20. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.